![Casey T. Weaver](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Casey T. Weaver
Corporate Officer/Principal chez The University of Alabama School of Medicine
Postes actifs de Casey T. Weaver
Sociétés | Poste | Début | Fin |
---|---|---|---|
The University of Alabama School of Medicine | Corporate Officer/Principal | 01/01/1992 | - |
Historique de carrière de Casey T. Weaver
Anciens postes connus de Casey T. Weaver
Sociétés | Poste | Début | Fin |
---|---|---|---|
University of Washington
![]() University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | - | - |
CARISMA THERAPEUTICS, INC. | Fondateur | 25/02/2008 | - |
Formation de Casey T. Weaver
University of Florida | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Opérationnelle
Corporate Officer/Principal | 2 |
Founder | 1 |
Doctorate Degree | 1 |
Sectorielle
Consumer Services | 4 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Sesen Bio, Inc.
![]() Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- Casey T. Weaver
- Expérience